e(ye)Brain launches an international clinical study

OREGA Biotech closes its second financing round
13 April 2013
GRAFTYS wins first prize (Deloitte Technology Fast 50)
27 November 2012

e(ye)Brain launches an international clinical study

The trial assesses oculomotor disorders in dyslexic children.